Promega Corp 2020 Sustainability Report
The report highlights Promega's broad capabilities across academic and government research, pharmaceutical and biotechnology, clinical diagnostics, environmental testing, and genetic identity. It describes support for COVID-19 diagnosis covering over 25 million samples in the first quarter, alongside applications in forensic and environmental testing. The company also reports allocating over 11% of total revenue to R&D and filing 79 new patents in 2019.
Company: Promega Corp
Sector: Manufacturing
Country: United States
Year: 2020
Type: Sustainability Report
Pages: 12
Back to company
Promega Corp
Corporate Responsibility Report
The report highlights Promega's broad capabilities across academic and government research, pharmaceutical and biotechnology, clinical diagnostics, environmental testing, and genetic identity. It describes support for COVID-19 diagnosis covering over 25 million samples in the first quarter, alongside applications in forensic and environmental testing. The company also reports allocating over 11% of total revenue to R&D and filing 79 new patents in 2019.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Fiscal Year
2020
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
No data available